Sorin Group Announces CE Mark Approval For The XL Version Of The Perceval(TM) Sutureless Aortic Valve

Sorin Group (MIL:SRN), (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, announced today it has received CE (Conformité Européenne) Mark approval for the XL version of Perceval.Perceval is a bioprosthetic device designed to replace a diseased native or malfunctioning prosthetic aortic valve using either traditional or minimally invasive heart surgery

Details:
www.businesswire.com/news/home/20131125005394/en/Sorin-Group-Announces-CE-Mark-Approval-XL